Interestingly, neutrophil numbers in the blood are an independent prognostic indicator of response to anti-VEGF therapy in patients with renal cell carcinoma, whereby increased neutrophil number correlates with a decreased overall survival following anti-VEGF therapy [82]. The gene discussed is VEGFA; the disease is hereditary clear cell renal cell carcinoma.